The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?

Lowe, G. and Rumley, A. (2014) The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us? Thrombosis and Haemostasis, 112(5), pp. 860-867. (doi: 10.1160/TH14-03-0199)

Full text not currently available from Enlighten.

Abstract

Several haemostatic factors have been associated with incident arterial cardiovascular disease in prospective studies and meta-analyses. Plasma fibrinogen shows a strong and consistent association with risk; however, this may reflect its inflammatory marker status, and causality remains to be proven. The common haemostatic gene polymorphisms for factor II, factor V and the von Willebrand factor: Factor VIII (non-O blood group) show significant associations with coronary heart disease (CHD) risk, consistent with potential causality. Increased D-dimer and t-PA antigen levels are associated with CHD risk, suggesting roles for coagulation activation and endothelial disturbance. There is little evidence for associations with CVD with other haemostatic factors.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Rumley, Dr Ann and Lowe, Professor Gordon
Authors: Lowe, G., and Rumley, A.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Thrombosis and Haemostasis
Publisher:Schattauer GmbH
ISSN:0340-6245

University Staff: Request a correction | Enlighten Editors: Update this record